Ryusuke Yoshimi1, Chiharu Hidekawa2, Natsuki Sakurai3, Nobuyuki Yajima4, Noriaki Kurita5, Naoki Suzuki3, Yuji Yoshioka3, Daiga Kishimoto6, Noriko Kojitani3, Yumiko Sugiyama3, Yosuke Kunishita7, Kana Higashitani3, Yuji Uzawa3, Yuichiro Sato3, Soichiro Adachi3, Yuki Iizuka3, Ayaka Maeda3, Lisa Hirahara3, Takaaki Komiya3, Yutaro Soejima3, Naoki Hamada3, Hideto Nagai3, Naomi Tsuchida3, Kaoru Takase-Minegishi3, Yohei Kirino3, Nao Oguro4, Keigo Hayashi8, Kenta Shidahara8, Yoshia Miyawaki8, Ken-ei Sada9, Dai Kishida10, Takanori Ichikawa11, Yasuhiro Shimojima10, Yuichi Ishikawa12, Shigeru Ohno13 and Hideaki Nakajima3, 1Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Kanazawa Ward, Yokohama Kanagawa, Japan, 2Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama City, Kanagawa Prefecture, Japan, 3Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Yokohama, Japan, 4Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan, 5Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, Fukushima, Japan, 6Center for Rheumatic Diseases, Yokohama City University Medical Center, Kanazawa-ku Yokohamashi, Japan, 7Department of Rheumatology, Yokohama Minami Kyosai Hospital, Yokohama, Kanagawa, Japan, 8Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan, 9Department of Clinical Epidemiology, Kochi Medical School, Kochi University, Okayama, Japan, 10Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan, 11Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, 12First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyusyu Fukuoka, Japan, 13Center for Rheumatic Disease, Yokohama City University Medical Center, Yokohama, Japan
Background/Purpose: In recent years, one of the overarching principles of EULAR recommendation is that systemic lupus erythematosus (SLE) treatment should be based on shared decision-making (SDM) between patients and physicians. However, it is unclear whether the degree of involvement of SLE patients in SDM contributes to their level of trust in their physicians. In this multicenter study, we investigated the relationship between the degree of involvement in SDM and the level of trust in physicians.
Methods: We collected data on the SDM-Q-9 shared decision-making scale (range 0-100), the Trust in Physician scale (TIPS; range 0-100), the Abbreviated Wake Forest Physician Trust Scale (A-WFPTS) for interpersonal trust in a physician (range 0-100), and the A-WFPTS for trust in the medical profession (range 0-100), in SLE patients aged 20 years or older who met the 1997 ACR revised classification criteria and were attending five facilities in Japan. We cross-sectionally examined the association between the SDM-Q-9 and each trust scale. In multiple regression analysis, we used age, sex, disease duration, SLE disease activity index, annual income, level of education, and marital status as adjusting variables, and missing values were complemented by multiple imputations.
Results: A total of 386 SLE patients (age 46.2 ± 14.3 years, 88.3% female) completed the questionnaire of this study. The SDM-Q-9 was positively correlated with three trust scales, TIPS, A-WFPTS for interpersonal trust in a physician, and A-WFPTS for trust in the medical profession (Spearman rank correlation coefficient rs = 0.64 [95%CI 0.57-0.70], p < 0.0001, rs = 0.69 [95%CI 0.63-0.74], p < 0.0001, and rs = 0.47 [95%CI 0.39-0.55], p < 0.0001, respectively). When 351 patients who did not have missing data in SDM-Q-9 and TIPS were divided into two groups, the higher SDM group (185 patients, median 87 [IQR 80-96]) and the lower SDM group (166 patients, 60 [51-67]), the higher SDM group had significantly higher TIPS than the lower SDM group (75 [68-82] vs. 66 [59-68], p < 0.0001). Multiple regression analysis showed that TIPS increased by 2.74 (95%CI 2.32-3.15, p < 0.001) for every ten increases in SDM-Q-9. Similarly, a multiple regression analysis of 366 patients who did not have missing data in SDM-Q-9 and A-WFPTS for interpersonal trust in a physician showed that A-WFPTS increased by 5.08 (95%CI 4.40-5.75, p < 0.001) for every ten increases in SDM-Q-9. Multiple regression analysis of 369 patients who did not have missing data in SDM-Q-9 and A-WFPTS for trust in the medical profession showed that A-WFPTS increased by 4.24 (95%CI 3.30-5.19, p < 0.001) for every ten increases in SDM-Q-9.
Conclusion: The degree of involvement of SLE patients in SDM was associated with their trust in their physicians and doctors in general.
Disclosures: R. Yoshimi, None; C. Hidekawa, None; N. Sakurai, None; N. Yajima, None; N. Kurita, None; N. Suzuki, None; Y. Yoshioka, None; D. Kishimoto, None; N. Kojitani, None; Y. Sugiyama, None; Y. Kunishita, None; K. Higashitani, None; Y. Uzawa, None; Y. Sato, None; S. Adachi, None; Y. Iizuka, None; A. Maeda, None; L. Hirahara, None; T. Komiya, None; Y. Soejima, None; N. Hamada, None; H. Nagai, None; N. Tsuchida, None; K. Takase-Minegishi, Gilead, Daiichi Sankyo, Mitsubishi Tanabe; Y. Kirino, None; N. Oguro, None; K. Hayashi, None; K. Shidahara, None; Y. Miyawaki, None; K. Sada, None; D. Kishida, None; T. Ichikawa, None; Y. Shimojima, None; Y. Ishikawa, None; S. Ohno, None; H. Nakajima, None.